# CORRESP — C4 Therapeutics, Inc.  (CCCC)  (CIK 0001662579)

> <strong>C4 Therapeutics, Inc.  (CCCC)  (CIK 0001662579) → SEC staff</strong> · filed 2025-12-08 · ticker CCCC · SIC 2836

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001628280-25-055804
- **Form:** CORRESP
- **Filer:** C4 Therapeutics, Inc.  (CCCC)  (CIK 0001662579)
- **CIK:** 0001662579
- **Ticker:** CCCC
- **Filed:** 2025-12-08
- **SIC industry:** 2836
- **HQ:** Watertown, MA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1662579/000162828025055804/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1662579&type=UPLOAD&dateb=&owner=include&count=40

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, C4 Therapeutics, Inc.  (CCCC)  (CIK 0001662579) (CIK 0001662579), filed 2025-12-08, accession 0001628280-25-055804. Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/comment-letter/0001628280-25-055804.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*